For the Patient: LUAVPG (Carboplatin Option)

Similar documents
ABOUT THIS MEDICATION What is this drug used for? Gemcitabine is an intravenous anticancer medication used for some types of cancer.

For the Patient: GIPAJGEM Other Names: Adjuvant chemotherapy for pancreatic cancer using Gemcitabine

For the Patient: GIPGEM Other Names: Metastatic cancer of the pancreas, gallbladder or bile duct.

For the Patient: LUAVPP (Carboplatin Option)

For the Patient: LUAVPG

For the Patient: LUPUPE (Carboplatin Option)

For the Patient: LUSCTOP

For the Patient: LUAJPC

For the Patient: GIAVPG Other Names: First-line palliative chemotherapy for advanced gallbladder and bile duct cancer using Gemcitabine and Cisplatin

For the Patient: ULUAVPMTN

For the Patient: LUAVNP

For the Patient: Fludarabine injection Other names: FLUDARA

For the Patient: LUAVPEM

For the Patient: PROTOCOL SMAVTMZ Other Names: Palliative Therapy for Malignant Melanoma with Brain Metastases Using Temozolomide

For the Patient: LUSCPE

For the Patient: LUAVPP

For the Patient: LUPUPE

For the Patient: Protocol LUAJNP Other names: Adjuvant Treatment of Non-Small Cell Lung Cancer with Cisplatin and Vinorelbine

For the Patient: Methotrexate Other names: MTX

For the Patient: Bendamustine Other names: TREANDA

For the Patient: Mitoxantrone Other names:

For the Patient: Eribulin Other names: HALAVEN

Sorafenib (so-ra-fe-nib) is a drug that is used to treat many types of cancer. It is a tablet that you take by mouth.

For the Patient: Amsacrine Other names: AMSA PD

For the Patient: HNAVFUP Treatment for Advanced Squamous Cell Cancer of the Head and Neck using Fluorouracil and Platinum

What are these drugs used for? Paclitaxel and carboplatin are intravenous anticancer medications used for many types of cancer.

Nilotinib (nil ot' i nib) is a drug that is used to treat some types of cancer. It is a capsule that you take by mouth.

For the Patient: Paclitaxel Other names: TAXOL

ABOUT THIS MEDICATION

For the Patient: Cyclosporine injection Other names: SANDIMMUNE I.V.

For the Patient: Epirubicin Other names: PHARMORUBICIN

For the Patient: Rituximab injection Other names: RITUXAN

For the Patient: Trastuzumab emtansine Other names: KADCYLA

For the Patient: GOOVCATM

For the Patient: GDP-R Other names: LYGDPR

For the Patient: GOOVDDCAT

For the Patient: GOOVCATR

For the Patient: Doxorubicin pegylated liposomal Other names: CAELYX, DOXIL, PLD

For the Patient: Olaparib tablets Other names: LYNPARZA

For the Patient: Ponatinib Other names: ICLUSIG

For the Patient: Alemtuzumab SC injection Other names: MABCAMPATH, CAMPATH

For the Patient: Cobimetinib tablets Other names: COTELLIC

For the Patient: Lenalidomide Other names: REVLIMID

For the Patient: GIA Other Names: Palliative chemotherapy for cancer of the liver (hepatoma) using Doxorubicin

For the Patient: Everolimus tablets Other names: AFINITOR

For the Patient: Sunitinib Other names: SUTENT

For the Patient: LULAPERT

U = Undesignated GI = GastroIntestinal AJ = Adjuvant RALOX = Raltitrexed, Oxaliplatin

For the Patient: GIENACTRT Treatment of esophageal and gastroesophageal cancer, prior to surgery, using Carboplatin, Paclitaxel and Radiation Therapy.

For the Patient: LUAVDC

For the Patient: SAAJAP

For the Patient: UGINETEV Other Names: Treatment of advanced neuroendocrine tumours of gastrointestinal origin (Non-Functional) using Everolimus

ABOUT THIS MEDICATION

For the Patient: GIAVPANI Other Names: Palliative third line treatment of metastatic cancer of the colon or rectum using Panitumumab

For the Patient: LUSCCAV

For the Patient: GOCXCATB

For the Patient: Lenvatinib Other names: LENVIMA

For the Patient: GIPE Palliative therapy of neuroendocrine tumours using Cisplatin and Etoposide

ABOUT THIS MEDICATION What are these drugs used for? Docetaxel is an anticancer drug used to treat cancers in the area of the neck and throat.

ABOUT THIS MEDICATION

For the Patient: GUBEP

For the Patient: GIPAJGCAP Other Names: Adjuvant chemotherapy for pancreatic adenocarcinoma using Gemcitabine and Capecitabine

For the Patient: UMYLDREL

You are being asked to take octreotide as a treatment to manage the symptoms of your cancer.

ABOUT THIS MEDICATION

For the Patient: LUOTPAC

For the Patient: GIPAVCAP Other Names: Second line treatment of metastatic or unresectable pancreatic adenocarcinoma using Capecitabine

For the Patient: Adjuvant therapy for breast cancer using weekly paclitaxel and trastuzumab (Herceptin)

For the Patient: USMAVFIPI

For the Patient: USMAVTRA Other Names: Treatment of BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma Using Trametinib

For the Patient: Vemurafenib Other names: ZELBORAF

For the Patient: ACTW Other names: BRAJACTW

Treatment Plan: Drugs:

(pack li TAX ell) For treating breast cancer, lung cancer, ovarian cancer, Kaposi's sarcoma or other cancers

For the Patient: DC. D Docetaxel (TAXOTERE ) C Cyclophosphamide

For the Patient: ULUAVPMB

For the Patient: Neoadjuvant therapy for locally advanced breast cancer using weekly paclitaxel followed by doxorubicin and cyclophosphamide

ABOUT THIS MEDICATION

For the Patient: USMAVNIV

For the Patient: USMAVPEM

= GastroIntestinal Gastric (stomach) = Advanced = Fluorouracil, Folinic Acid, OXaliplatin ABOUT THIS MEDICATION

For the Patient: GIAJCAPOX Other Names: Adjuvant combination chemotherapy for Stage III and IIB colon cancer using capecitabine and oxaliplatin.

For the Patient: Afatinib Other names: GIOTRIF, GILOTRIF

For the Patient: GIAVTZCAP Other Names: Palliative therapy of metastatic neuroendocrine cancer of the pancreas, using Temozolomide and Capecitabine

For the Patient: CAP. Capecitabine. Uses:

For the Patient: ACD

For the Patient: GUPDOCADT

GI = GastroIntestinal FOLFIRI = Folinic Acid, Fluorouracil, Irinotecan

This therapy is being given to treat your cancer of the anal canal with the intention of cure.

For the Patient: GICART Other Names: Curative therapy for cancer of the anal canal using combined Mitomycin, Capecitabine and Radiation Therapy

What are these drugs used for? Oxaliplatin, bevacizumab and capecitabine are drugs given to treat cancer of the colon or rectum.

For the Patient: LYEPOCHR Other Names: DA-EPOCHR

ABOUT THIS MEDICATION

For the Patient: GIRCRT Adjuvant therapy for high risk cancer of the rectum with combined Capecitabine and Radiation Therapy

ABOUT THIS MEDICATION

What are these drugs used for? Irinotecan, fluorouracil (5FU), leucovorin and bevacizumab are drugs given to treat colon or rectal cancer.

For the Patient: USMAVVC Other Names: Treatment of BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma Using Vemurafenib and Cobimetinib

GI = GastroIntestinal FIRINOX = Fluorouracil, Irinotecan, Infusional fluorouracil, Oxaliplatin

What are these drugs used for? Irinotecan, fluorouracil (5FU), leucovorin, and panitumumab are drugs given to treat metastatic colorectal cancer.

Transcription:

For the Patient: LUAVPG (Carboplatin Option) Other Names: Treatment of Advanced n-small Cell Lung Cancer with Carboplatin and Gemcitabine LU = LUng AV = AdVanced PG = CarboPlatin, Gemcitabine ABOUT THIS MEDICATION What are these drugs used for? LUAVPG is an intravenous (through the vein) drug treatment for n-small Cell Lung Cancer. The goal of this treatment is to help control or shrink the cancer and some of the symptoms caused by it. How do these drugs work? Carboplatin is an anticancer drug that works by preventing the synthesis of DNA that is needed for cancer cells to divide. Gemcitabine is an anticancer drug that works by preventing the synthesis and repair of DNA that is needed for cancer cells to divide. INTENDED BENEFITS This treatment is being given to destroy and/or slow down the growth of cancer cells in your body. This treatment may improve your current symptoms, and delay or prevent new symptoms from starting. This therapy treatment can also help with controlling some of the symptoms the cancer may be causing, such as pain, coughing, wheezing, difficulty swallowing, weight loss and fatigue. Research has shown that patients may live longer after receiving therapy treatment. LUAVPG TREATMENT SUMMARY How are these drugs given? Your treatment plan consists of up to 6 therapy cycles. Each cycle lasts 3 weeks (21 days). For each cycle, you will have two medications given to you intravenously (through the vein) on Day 1. - Gemcitabine is given first, and is given intravenously over half-an-hour (30 minutes). - Carboplatin is given last, and is also given intravenously over half-an-hour (30 minutes). BC Cancer Agency Protocol Summary (Patient Version) LUAVPG (Carboplatin Option) 1/7

On Day 8 of each cycle, you will only be given Gemcitabine, intravenously, over halfan-hour (30 minutes). What will happen when I get my drugs? A blood test is done within one month of starting treatment. A blood test is also done before Day 1 and Day 8 of each cycle. The dose and timing of your therapy may be changed based on your blood test results and/or other side effects. Your very first treatment will take longer than other treatments because a nurse will be reviewing the possible side effects of your therapy plan and will discuss with you how to manage them. It is a good idea to bring someone with you to your first therapy appointment. You will be given a prescription for anti-nausea medications (to be filled at your regular pharmacy). Please bring your anti-nausea medications with you for each treatment. Your nurse will tell you when to take the anti-nausea medication. You may also need to take your anti-nausea drugs at home after therapy. It is easier to prevent nausea than to treat it once it happens, so follow directions closely. LUAVPG TREATMENT PROTOCOL Start Date: Cycle 1: Day 1 Day 2 Day 3 Day 4 Day 5 Day 6 Day 7 Blood test, Gemcitabine & Carboplatin Day 8 Day 9 Day 10 Day 11 Day 12 Day 13 Day 14 Blood test, Gemcitabine Day 15 Day 16 Day 17 Day 18 Day 19 Day 20 Day 21 Chemo This 21-day cycle will repeat up to 5 more times. BC Cancer Agency Protocol Summary (Patient Version) LUAVPG (Carboplatin Option) 2/7

CHEMOTHERAPY SIDE EFFECTS AND MANAGEMENT Are there any risks? Unexpected and unlikely side effects can occur with any drug treatment. The ones listed below are particularly important for you to be aware of. SERIOUS SIDE EFFECTS Your white blood cells may decrease after your treatment. They usually return to normal in 2-3 weeks. White blood cells protect your body by fighting bacteria (germs) that cause infection. When they are low, you are at greater risk of having an infection. Your platelets may decrease after your treatment. They usually return to normal in 2-3 weeks. Platelets help to make your blood clot when you hurt yourself. You may bruise or bleed more easily than usual. How common is it? Very Common Common MANAGEMENT To help prevent infection: Wash your hands often and always after using the bathroom. Take care of your skin and mouth by gently washing regularly. Avoid crowds and people who are sick. Call your doctor immediately at the first sign of an infection such as fever (over 100 F or 38 C by an oral thermometer), chills, cough or burning when you pass urine. To help prevent bleeding problems: Try not to bruise, cut or burn yourself. Clean your nose by blowing gently, do not pick your nose. Avoid constipation. Brush your teeth gently with a soft toothbrush as your gums may bleed more easily. Maintain good oral hygiene. Avoid taking ASA (eg: Aspirin ) or Ibuprofen (eg: Advil ), unless prescribed by your doctor. BC Cancer Agency Protocol Summary (Patient Version) LUAVPG (Carboplatin Option) 3/7 periodic basis. The date of last revision will be visible on each page of a protocol summary. Any physician using the protocol summaries to provide treatment for patients will be solely responsible for verifying the doses, providing the

OTHER SIDE EFFECTS Nausea and vomiting may occur after your treatment and may last for 24 hours. It is usually mild to moderate. Tiredness and lack of energy may occur. A flu-like illness may occur shortly after your treatment. You may have fever, chills, headache, muscle and joint aches. Flu-like symptoms usually disappear on their own. Skin rash may occur after treatment. It is usually mild and is found on the arms, legs, chest, back or stomach. It may or may not be itchy. Pain or tenderness may occur where the needle was placed in your vein. Swelling of hands, feet or lower legs may occur if your body retains extra fluid How Common Is It? BC Cancer Agency Protocol Summary (Patient Version) LUAVPG (Car boplatin Option) 4/7 MANAGEMENT Very Common You will be given a prescription for anti-nausea drug(s) to take before your therapy treatment and/or at home. It is easier to prevent nausea than to treat it once it has happened, so follow directions closely. Drink plenty of liquids. Eat and drink often in small amounts. Try the ideas in Food Choices to Control Nausea. Be sure to let your doctor know if you have nausea or vomiting later than 24 hours after your treatment. Very Common Do not drive a car or operate machinery if you are feeling tired. Try the ideas in Your Bank of Energy Savings: How People with Cancer can Handle Fatigue. Common Take acetaminophen (Tylenol ) every 3-4 hours if needed. Fever and chills which occur more than 48 hours after treatment may be signs of an infection. They should be reported to the doctor immediately. Common Apply hydrocortisone cream 0.5% sparingly 3-4 times daily. Common Apply cool compresses or soak in cool water for 15-20 minutes several times a day. Uncommon If swelling is a problem: o Elevate your feet when resting o Avoid tight clothing periodic basis. The date of last revision will be visible on each page of a protocol summary. Any physician using the protocol summaries to provide treatment for patients will be solely responsible for verifying the doses, providing the

OTHER SIDE EFFECTS Hair loss sometimes occurs. If there is hair loss, your hair will grow back once you stop treatment. Colour and texture may change. How Common Is It? MANAGEMENT Uncommon Use a gentle shampoo and soft brush. Care should be taken with use of hair spray, bleaches, dyes and perms. Refer to the pamphlet For the Patient: Hair loss due to therapy Diarrhea may occur. Uncommon To help diarrhea: Drink plenty of liquids. Eat and drink often in small amounts. Avoid high fibre foods as outlined in Food Ideas to Help with Diarrhea during Chemotherapy. BC Cancer Agency Protocol Summary (Patient Version) LUAVPG (Carboplatin Option) 5/7 The BCCA Protocol Summaries are those in current use by the BCC Systemic Therapy Program staff at all four regional cancer centres. Both the format and content of the summaries will change as they are reviewed and revised on a periodic basis. The date of last revision will be visible on each page of a protocol summary. Any physician using the protocol summaries to provide treatment for patients will be solely responsible for verifying the doses, providing the

INSTRUCTIONS FOR THE PATIENT What other drugs can interact with LUAVPG? Other drugs such as phenytoin (DILANTIN ) and warfarin (COUMADIN ) may interact with LUAVPG. Tell your doctor if you are taking these or other drugs as you may need extra blood tests, your dose may need to be changed or your treatment may need to be held for a few days. Check with your doctor or pharmacist before you start taking any new prescription or non-prescription drugs. Other important things to know: The drinking of alcohol (in small amounts) does not appear to affect the safety or usefulness of this treatment. This treatment may cause sterility in men and menopause in women. If you plan to have children, discuss this with your doctor before starting treatment. This treatment may damage sperm and may cause harm to the baby if used during pregnancy. It is best to use birth control while you are undergoing treatment. Tell your doctor right away if you or your partner becomes pregnant. Do not breast feed during treatment. Tell all doctors or dentists you see that you being treated with Carboplatin and Gemcitabine before you receive treatment of any form. SEE YOUR DOCTOR OR GET EMERGENCY HELP IMMEDIATELY IF YOU HAVE: Signs of an infection such as fever (over 100 F or 38 C by an oral thermometer); chills, cough, pain or burning when you pass urine. Signs of bleeding problems such as black, tarry stools; blood in urine or pinpoint red spots on skin. Signs of an allergic reaction (rare) soon after a treatment including dizziness, fast heart beat, face swelling or breathing problems. Signs of heart problems such as fast or uneven heartbeat. Signs of lung problems such as shortness of breath or difficulty breathing. SEE YOUR DOCTOR AS SOON AS POSSIBLE (DURING OFFICE HOURS) IF YOU HAVE: Changes in eyesight. Ringing in your ears or hearing problems. Signs of kidney problems such as lower back or side pain, swelling of feet or lower legs. Skin rash or itching. Signs of anemia such as unusual tiredness or weakness. Stomach pain not controlled by antacids or acetaminophen. Signs of liver problems such as yellow eyes or skin, white or clay-coloured stools. BC Cancer Agency Protocol Summary (Patient Version) LUAVPG (Carboplatin Option) 6/7

CHECK WITH YOUR DOCTOR IF ANY OF THE FOLLOWING CONTINUE TO BOTHER YOU: Easy bruising or bleeding. Uncontrolled nausea, vomiting, constipation or diarrhea. Redness, swelling, pain or sores where the needle was placed. Redness, swelling, pain or sores on your lips, tongue, mouth or throat. Skin rash with or without itching. Excessive drowsiness. Aches and pains. If you experience symptoms or changes in your body that have not been described above but worry you, or if any symptoms are severe, contact: at telephone number BC Cancer Agency Protocol Summary (Patient Version) LUAVPG (Carboplatin Option) 7/7